For example, the prognostic weight of CLR is conceptually consistent with the well-documented roles of its components: CRP, an acute-phase reactant driven by pro-inflammatory cytokines like IL-6, and lymphocytes, essential for adaptive anti-tumor immunity. This evidence concerns the gene IL6 and neoplasm.